Loading
Find Us on Facebook Follow Us on Twitter Bookmark & Share Subscribe to Feed
Wanna join our 6011 other users? | Register
Menu 

BIO SmartBrief

BiotechBlog

  • Mistakes to Be Avoided When Preparing a Drug Launch

    Mistakes to Be Avoided When Preparing a Drug Launch

    The launch of a new product can be a daunting task. The main reason this happens is that no matter how many times your company has managed to enter new…The post Mistakes to Be Avoided When Preparing a Drug Launch appeared first on DrugPatentWatch…
    - 14 days ago, 31 Oct 19, 10:27am -
  • Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984

    Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984

    This article was originally published by Garth Boehm, Lixin Yao, Liang Hana, and Qiang Zheng in Acta Pharmaceutica Sinica under a creative commons license. Abstract The key events in the…The post Development of the generic drug industry in the US…
    - 16 days ago, 29 Oct 19, 3:56pm -
  • Customer Success: How do we identify generic entrants before they get FDA approval?

    Customer Success: How do we identify generic entrants before they get FDA approval?

    DrugPatentWatch can help identify generic entrants at the earliest stages Many clients come to DrugPatentWatch seeking to identify generic entrants well before they launch. CDMOs, equipment manufacturers, regulatory consultants, and…The post Custo…
    - 21 days ago, 24 Oct 19, 3:07pm -
  • DrugPatentWatch Headlines Swissbiotech Annual Report

    DrugPatentWatch Headlines Swissbiotech Annual Report

    The latest Swiss Biotech annual report focuses on the theme of shaping change. Change is a theme DrugPatentWatch is very familiar with — whether it is a matter of tracking…The post DrugPatentWatch Headlines Swissbiotech Annual Report appeared fi…
    - 31 days ago, 14 Oct 19, 9:56am -
  • Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection

    Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection

    This article was originally published by Christopher M. Holman* in Intellectual Property Watch under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Despite the important role of intellectual property rights in…T…
    - 41 days ago, 4 Oct 19, 2:40pm -
  • The Influence of Emerging Markets on the Pharmaceutical Industry

    The Influence of Emerging Markets on the Pharmaceutical Industry

    This paper was originally published by  Maya Tannoury and Zouhair Attieh in Current Therapeutic Research under a creative commons license. Abstract Emerging markets represent an exceptional opportunity for the pharmaceutical…The post The Influenc…
    - 46 days ago, 29 Sep 19, 3:54pm -
  • Alternative Data for Biotechnology and Pharmaceutical Financial Modeling and Time Series Analysis

    Alternative Data for Biotechnology and Pharmaceutical Financial Modeling and Time Series Analysis

    BUILD AND BACKTEST YOUR FINANCIAL MODELS WITH ANNOTATED DRUG PATENTS, SALES, AND LITIGATION   Apply your financial models to our data Keep your models fresh with our live patent data…The post Alternative Data for Biotechnology and Pharmaceutical…
    - 49 days ago, 26 Sep 19, 1:36pm -
  • Reviving a Discontinued Drug

    Reviving a Discontinued Drug

    When drugs are taken off the market because of concerns about their safety, it makes headlines. To access DrugPatentWatch’s list of discontinued drugs try a free trial or contact us…The post Reviving a Discontinued Drug appeared first on DrugPat…
    - 52 days ago, 23 Sep 19, 5:34pm -
  • Finding and Evaluating Branded and Generic Market Entry Opportunities

    Finding and Evaluating Branded and Generic Market Entry Opportunities

    Here’s a copy of the recent talk on Finding and Evaluating Branded and Generic Market Entry Opportunities. It’s based on the book Make Better Decisions, which distills insights gained from…The post Finding and Evaluating Branded and Generic Ma…
    - 52 days ago, 23 Sep 19, 11:16am -
  • Drug Prices and Generic Competition

    Drug Prices and Generic Competition

    You would be surprised to find out just how many questions are answered by the analysis of the relationship that emerges between generic competition and drug prices.  For manufacturers and…The post Drug Prices and Generic Competition appeared fir…
    - 63 days ago, 12 Sep 19, 1:51pm -

BIOtechNow

Nature: Biotechnology

  • Dose-dependent activation of gene expression is achieved using CRISPR and small molecules that recruit endogenous chromatin machinery

    Dose-dependent activation of gene expression is achieved using CRISPR and small molecules that recruit endogenous chromatin machinery

    Nature Biotechnology, Published online: 11 November 2019; doi:10.1038/s41587-019-0296-7Activation of gene expression with chemical epigenetic modifiers
    - 4 days ago, 10 Nov 19, 7:00pm -
  • Pancreatic nerve electrostimulation inhibits recent-onset autoimmune diabetes

    Pancreatic nerve electrostimulation inhibits recent-onset autoimmune diabetes

    Nature Biotechnology, Published online: 11 November 2019; doi:10.1038/s41587-019-0295-8Autoimmune diabetes in mice is averted by electrically stimulating the nerve projecting to the pancreas.
    - 4 days ago, 10 Nov 19, 7:00pm -
  • AI developers tout revolution, drugmakers talk evolution

    AI developers tout revolution, drugmakers talk evolution

    Nature Biotechnology, Published online: 08 November 2019; doi:10.1038/d41587-019-00033-4Artificial intelligence-powered drug discovery is capturing breathless headlines, drug company deals, and investor capital, but the acceleration it promises will…
    - 7 days ago, 7 Nov 19, 7:00pm -
  • Gene editing enters ‘prime’ time

    Gene editing enters ‘prime’ time

    Nature Biotechnology, Published online: 07 November 2019; doi:10.1038/d41587-019-00032-5Early results suggest that prime editors are cleaner than CRISPR–Cas9 and more versatile than base editors, but many questions remain.
    - 8 days ago, 6 Nov 19, 7:00pm -
  • The next biotech superpower

    The next biotech superpower

    Nature Biotechnology, Published online: 05 November 2019; doi:10.1038/s41587-019-0316-7China is set to challenge the pre-eminence of the US drug market. If it can address gaps in its R&D ecosystem and clinical infrastructure, it may even become a hom…
    - 10 days ago, 4 Nov 19, 7:00pm -
  • Race for undruggable KRAS speeds up

    Race for undruggable KRAS speeds up

    Nature Biotechnology, Published online: 05 November 2019; doi:10.1038/s41587-019-0312-yRace for undruggable KRAS speeds up
    - 10 days ago, 4 Nov 19, 7:00pm -
  • Microbiomes

    Microbiomes

    Nature Biotechnology, Published online: 05 November 2019; doi:10.1038/s41587-019-0309-6Recent patents related to methods of assessing microbiome health and treatments of microbiome-related conditions.
    - 10 days ago, 4 Nov 19, 7:00pm -
  • 3Q19—Biotech funding stagnates

    3Q19—Biotech funding stagnates

    Nature Biotechnology, Published online: 05 November 2019; doi:10.1038/s41587-019-0307-83Q19—Biotech funding stagnates
    - 10 days ago, 4 Nov 19, 7:00pm -

Phys.org: Biotechnology

Scientific American: Biotechnology

MyPopMuse
Jobthusiast Job Search
Emergency Comeback
Shorts Fix
Shorts Fix

About PopMuse

A curated aggregation of musings from across the land and of different subject matters for the scanoholics.